Shimamoto Masako, Gotoh Kumiko, Hasegawa Koki, Kojima Akihiro
Department of Radioisotope Science, Graduate School of Medical Sciences, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan.
Department of Radioisotope Science, Institute of Resource Development and Analysis, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan.
Mol Imaging Biol. 2016 Aug;18(4):500-9. doi: 10.1007/s11307-016-0928-y.
Cerenkov luminescence imaging (CLI) has recently emerged as a molecular imaging modality for radionuclides emitting β-particles. The aim of this study was to develop a hybrid light imaging (HLI) technique using a liquid scintillator to assist CLI by increasing the optical signal intensity from both β-particle and γ-ray emitting radionuclides located at deep regions in vivo.
A commercial optical imaging system was employed to collect all images by HLI and CLI. To investigate the performance characteristics of HLI with a commercially available liquid scintillator (Emulsifier-safe), phantom experiments were conducted for two typical β-particle and γ-ray emitters, sodium iodide (Na[(131)I]I) and 2-deoxy-2-[(18)F]fluoro-D-glucose ([(18)F]FDG), respectively. To evaluate the feasibility of HLI for in vivo imaging, HLI was applied to a Na[(131)I]I injected nu/nu mouse and an [(18)F]FDG injected Balb-c mouse and compared with CLI alone.
Measured HLI wavelength spectra with Emulsifier-safe showed higher signal intensities than for CLI at 500-600 nm. For material preventing light transmission of 12-mm thickness, CLI imaging provided quite low intensity and obscure signals of the source. However, despite degraded spatial resolution, HLI imaging provided sustained visualization of the source shape, with signal intensities 10-14 times higher than for CLI at 10-mm thickness. Furthermore, at 0, 4, and 8-mm material thicknesses, HLI showed a strong correlation between Na[(131)I]I or [(18)F]FDG radioactivity and signal intensity, as for CLI. In vivo studies also demonstrated that HLI could successfully visualize Na[(131)I]I uptake in the mouse thyroid gland in the prone position and [(18)F]FDG accumulation in the heart in the supine position, which were not observed with CLI.
Our preliminary studies suggest that HLI can provide enhanced imaging of a β-particle probe emitting together with γ-rays at deep tissue locations. HLI may be a promising imaging technique to assist with preclinical in vivo imaging using CLI.
切伦科夫发光成像(CLI)最近已成为一种用于发射β粒子的放射性核素的分子成像方式。本研究的目的是开发一种混合光成像(HLI)技术,使用液体闪烁体通过增加位于体内深部区域的发射β粒子和γ射线的放射性核素的光信号强度来辅助CLI。
使用商业光学成像系统通过HLI和CLI收集所有图像。为了研究使用市售液体闪烁体(Emulsifier-safe)的HLI的性能特征,分别针对两种典型的β粒子和γ射线发射体碘化钠(Na[(131)I]I)和2-脱氧-2-[(18)F]氟-D-葡萄糖([(18)F]FDG)进行了体模实验。为了评估HLI用于体内成像的可行性,将HLI应用于注射了Na[(131)I]I的nu/nu小鼠和注射了[(18)F]FDG的Balb-c小鼠,并与单独的CLI进行比较。
使用Emulsifier-safe测量的HLI波长光谱在500 - 600 nm处显示出比CLI更高的信号强度。对于厚度为12 mm的光传输阻挡材料,CLI成像提供的源强度相当低且信号模糊。然而,尽管空间分辨率有所下降,但HLI成像仍能持续显示源的形状,在10 mm厚度时信号强度比CLI高10 - 14倍。此外,在材料厚度为0、4和8 mm时,HLI显示出与CLI一样,Na[(131)I]I或[(18)F]FDG放射性与信号强度之间有很强的相关性。体内研究还表明,HLI能够成功地在俯卧位小鼠甲状腺中可视化Na[(131)I]I的摄取,在仰卧位小鼠心脏中可视化[(18)F]FDG的蓄积,而CLI未观察到这些情况。
我们的初步研究表明,HLI可以在深部组织位置对与γ射线一起发射的β粒子探针进行增强成像。HLI可能是一种有前景的成像技术,可辅助使用CLI进行临床前体内成像。